European Region has the heaviest alcohol consumption of all regions in the world, causing a significant reduction in life expectancy, especially among men. Approximately 800,000 lives are lost each ...

Axiomer ADAR-mediated RNA editing pipeline advancing across liver and CNS programs, with CTA filing on track for Q2 2025 for lead program AX-0810 targeting NTCP for Cholestatic diseases Strengthened ...

The findings, published in BMC Oral Health, suggest that incorporating routine oral health assessments into the management of ...

An experimental new treatment is showing early promise in the fight against liver fibrosis—a serious and often silent ...

While cinnamon is a popular spice used added to many foods, it has a long history of uses in traditional medicine in many ...

Experts highlight ten common requests received in their Gastroenterology advice and guidance service and explain how these ...

Korro Bio is laying off a fifth of its workforce as the Novo Nordisk-partnered biotech funnels resources to its ...

Signs your nails reveal about liver health decline with early changes like pale beds, ripples, white bands, yellowing, and ...

GSK has shared the data behind its phase 3 liver disease win, revealing patients on linerixibat reported reductions in ...

Announce initial clinical data from Cohort 1 in the Phase 1/2 trial of PM359 for p47 phox CGD in 2025. The initial readout ...

Dr. Falk Pharma’s norucholic acid (NCA) drug has demonstrated potential in a Phase III trial for primary sclerosing ...

Liver disease patients are falling through the cracks and not getting the treatment they need. Support from people with lived experience of disease could bridge the gap.